View in EDS HTML Full Text PDF Full Text

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Saved in:
Bibliographic Details
Title: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Authors: Clemens SAC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Institute of Global Health, University of Siena, Siena, Italy., Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil., Ratcliff J; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., De Almeida Mendes AV; Escola Bahiana de Medicina e Saúde Pública, Brazil and ID'OR, Salvador, Brazil.; Hospital São Rafael, Salvador, Brazil., Milan EP; Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil., Pittella A; Hospital Quinta D'Or, Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Universidade Unigranrio, Rio de Janeiro, Brazil., Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil., Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bonsall D; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fraser C; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kelly S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Simmonds P; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Golubchik T; Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. merryn.voysey@paediatrics.ox.ac.uk., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.pollard@paediatrics.ox.ac.uk.
Corporate Authors: AMPHEUS Project, Oxford COVID Vaccine Trial Team
Source: Nature communications [Nat Commun] 2021 Oct 06; Vol. 12 (1), pp. 5861. Date of Electronic Publication: 2021 Oct 06.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34615860
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Clemens+SAC%22">Clemens SAC</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Institute of Global Health, University of Siena, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Folegatti+PM%22">Folegatti PM</searchLink>; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Emary+KRW%22">Emary KRW</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Weckx+LY%22">Weckx LY</searchLink>; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Ratcliff+J%22">Ratcliff J</searchLink>; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bibi+S%22">Bibi S</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22De+Almeida+Mendes+AV%22">De Almeida Mendes AV</searchLink>; Escola Bahiana de Medicina e Saúde Pública, Brazil and ID'OR, Salvador, Brazil.; Hospital São Rafael, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Milan+EP%22">Milan EP</searchLink>; Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil.<br /><searchLink fieldCode="AU" term="%22Pittella+A%22">Pittella A</searchLink>; Hospital Quinta D'Or, Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Universidade Unigranrio, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Schwarzbold+AV%22">Schwarzbold AV</searchLink>; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.<br /><searchLink fieldCode="AU" term="%22Sprinz+E%22">Sprinz E</searchLink>; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Aley+PK%22">Aley PK</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bonsall+D%22">Bonsall D</searchLink>; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Fraser+C%22">Fraser C</searchLink>; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Fuskova+M%22">Fuskova M</searchLink>; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gilbert+SC%22">Gilbert SC</searchLink>; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Jenkin+D%22">Jenkin D</searchLink>; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kelly+S%22">Kelly S</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kerridge+S%22">Kerridge S</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Lambe+T%22">Lambe T</searchLink>; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Marchevsky+NG%22">Marchevsky NG</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Mujadidi+YF%22">Mujadidi YF</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Plested+E%22">Plested E</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ramasamy+MN%22">Ramasamy MN</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Simmonds+P%22">Simmonds P</searchLink>; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Golubchik+T%22">Golubchik T</searchLink>; Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Voysey+M%22">Voysey M</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. merryn.voysey@paediatrics.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.pollard@paediatrics.ox.ac.uk.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22AMPHEUS+Project%22">AMPHEUS Project</searchLink><br /><searchLink fieldCode="CA" term="%22Oxford+COVID+Vaccine+Trial+Team%22">Oxford COVID Vaccine Trial Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Oct 06; Vol. 12 (1), pp. 5861. <i>Date of Electronic Publication: </i>2021 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34615860
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-25982-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5861
    Titles:
      – TitleFull: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Clemens SAC
      – PersonEntity:
          Name:
            NameFull: Folegatti PM
      – PersonEntity:
          Name:
            NameFull: Emary KRW
      – PersonEntity:
          Name:
            NameFull: Weckx LY
      – PersonEntity:
          Name:
            NameFull: Ratcliff J
      – PersonEntity:
          Name:
            NameFull: Bibi S
      – PersonEntity:
          Name:
            NameFull: De Almeida Mendes AV
      – PersonEntity:
          Name:
            NameFull: Milan EP
      – PersonEntity:
          Name:
            NameFull: Pittella A
      – PersonEntity:
          Name:
            NameFull: Schwarzbold AV
      – PersonEntity:
          Name:
            NameFull: Sprinz E
      – PersonEntity:
          Name:
            NameFull: Aley PK
      – PersonEntity:
          Name:
            NameFull: Bonsall D
      – PersonEntity:
          Name:
            NameFull: Fraser C
      – PersonEntity:
          Name:
            NameFull: Fuskova M
      – PersonEntity:
          Name:
            NameFull: Gilbert SC
      – PersonEntity:
          Name:
            NameFull: Jenkin D
      – PersonEntity:
          Name:
            NameFull: Kelly S
      – PersonEntity:
          Name:
            NameFull: Kerridge S
      – PersonEntity:
          Name:
            NameFull: Lambe T
      – PersonEntity:
          Name:
            NameFull: Marchevsky NG
      – PersonEntity:
          Name:
            NameFull: Mujadidi YF
      – PersonEntity:
          Name:
            NameFull: Plested E
      – PersonEntity:
          Name:
            NameFull: Ramasamy MN
      – PersonEntity:
          Name:
            NameFull: Simmonds P
      – PersonEntity:
          Name:
            NameFull: Golubchik T
      – PersonEntity:
          Name:
            NameFull: Voysey M
      – PersonEntity:
          Name:
            NameFull: Pollard AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 10
              Text: 2021 Oct 06
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1